drugset / Trial / NCT01111851
Aprepitant and Fosaprepitant Time-on-Target PET (Positron Emission Tomography) Study (0869-183)
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will evaluate if the mean value of brain neurokinin 1 (NK1)-receptor occupancy of participants treated with aprepitant is similar to that of participants treated with fosaprepitant at certain timepoints.
Timeline
- Start
- 2010-04
- Primary completion
- 2010-10
- Completion
- 2010-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aprepitant | Other / unclassified | 165 mg | Oral |
| Subject | Aprepitant | Other / unclassified | 250 mg | Oral |
| Subject | Fosaprepitant | Other / unclassified | 150 mg | Intravenous |
| Subject | MK0999 | Unknown | 5 ug | Intravenous |
| Subject | MK0999 | Unknown | 100 mbq | Intravenous |
| Background | Dexamethasone | Small molecule | 8 mg | Oral |
| Background | Ondansetron | Other / unclassified | 32 mg | Intravenous |